Aktana has been acquired by PharmaForceIQ to create a pioneering optichannel engagement solution for the pharmaceutical industry.

Information on the Target

Aktana is a frontrunner in intelligent customer engagement solutions for the life sciences sector. The company focuses on enhancing customer interactions through data-driven insights, allowing pharmaceutical companies to effectively engage healthcare professionals (HCPs) and patients. They specialize in implementing advanced strategies that foster strong relationships in the complex pharmaceutical landscape, particularly through their innovative Next-Best-Action (NBA) platform.

By integrating state-of-the-art AI technologies, Aktana enables pharmaceutical companies to streamline their commercial customer engagement processes. The company's comprehensive approach aids in understanding HCP preferences and behaviors, ultimately driving better engagement and outcomes for clients in the life sciences industry.

Industry Overview in the Target's Specific Country

The pharmaceutical industry in the United States is experiencing rapid transformation fueled by technological advancements and changing market dynamics. As companies increasingly seek to leverage d